Description
Rybelsus 7mg tablet is an oral GLP-1 receptor agonist containing semaglutide, designed for adults managing type 2 diabetes or weight-related conditions. It mimics the body’s GLP-1 hormone to improve blood sugar control, suppress appetite, and support weight reduction—all in an easy, once-daily tablet form.
Rybelsus 7mg Tablet Key Features:
-
Oral GLP-1 treatment—no injections required
-
Contains 7mg semaglutide per tablet
-
Helps control appetite and lower blood glucose levels
-
Clinically proven to support weight management (NEJM study)
-
Convenient once-daily dosing
Usage Instructions:
-
Take once daily with a small sip of water, at least 30 minutes before food or other medications
-
Swallow whole; do not crush or chew
-
Follow the dosage schedule provided by your healthcare provider (commonly starts at 3mg before progressing to 7mg or 14mg)
Rybelsus 7mg Tablet Side Effects:
Mild side effects may include nausea, bloating, or diarrhea. Most symptoms lessen as your body adjusts. For complete safety information, visit the FDA Rybelsus Guide.
Storage Instructions:
-
Store at room temperature (68°F–77°F / 20°C–25°C)
-
Keep tablets in their original blister pack until use
-
Protect from moisture and direct sunlight
Reviews
There are no reviews yet.